- Home
- DAN vs BEAM Comparison
DAN vs BEAM Comparison
Compare DAN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAN
- BEAM
- Stock Information
- Founded
- DAN 1904
- BEAM 2017
- Country
- DAN United States
- BEAM United States
- Employees
- DAN N/A
- BEAM N/A
- Industry
- DAN Auto Parts:O.E.M.
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DAN Consumer Discretionary
- BEAM Health Care
- Exchange
- DAN Nasdaq
- BEAM Nasdaq
- Market Cap
- DAN 2.4B
- BEAM 2.3B
- IPO Year
- DAN N/A
- BEAM 2020
- Fundamental
- Price
- DAN $21.79
- BEAM $22.72
- Analyst Decision
- DAN Buy
- BEAM Strong Buy
- Analyst Count
- DAN 5
- BEAM 11
- Target Price
- DAN $26.00
- BEAM $49.40
- AVG Volume (30 Days)
- DAN 2.1M
- BEAM 2.5M
- Earning Date
- DAN 10-29-2025
- BEAM 11-04-2025
- Dividend Yield
- DAN 1.84%
- BEAM N/A
- EPS Growth
- DAN N/A
- BEAM N/A
- EPS
- DAN 0.39
- BEAM N/A
- Revenue
- DAN $9,957,000,000.00
- BEAM $55,701,000.00
- Revenue This Year
- DAN N/A
- BEAM N/A
- Revenue Next Year
- DAN N/A
- BEAM $19.01
- P/E Ratio
- DAN $55.72
- BEAM N/A
- Revenue Growth
- DAN 17.78
- BEAM N/A
- 52 Week Low
- DAN $7.72
- BEAM $13.53
- 52 Week High
- DAN $22.13
- BEAM $35.25
- Technical
- Relative Strength Index (RSI)
- DAN 64.85
- BEAM 43.06
- Support Level
- DAN $20.89
- BEAM $21.16
- Resistance Level
- DAN $22.00
- BEAM $23.36
- Average True Range (ATR)
- DAN 0.75
- BEAM 1.55
- MACD
- DAN 0.15
- BEAM -0.59
- Stochastic Oscillator
- DAN 87.79
- BEAM 20.99
About DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.